Clinical Trial Update: ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pemetrexed (ALIMTA) with cisplatin or with carboplatin in extensive-stage small cell lung cancer; status indicates the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lung Neoplasms | Phase 2 | Status: COMPLETED